Postvaccinal, Corticosteroid-resistant Bullous Pemphigoid in Infancy: Treatment with Intravenous Immunoglobulin
Article first published online: 11 JUN 2014
© 2014 Wiley Periodicals, Inc.
Volume 31, Issue 4, pages e94–e95, July/August 2014
How to Cite
Ister, M., Pouessel, G., Ythier, H., Catteau, B. and Carpentier, O. (2014), Postvaccinal, Corticosteroid-resistant Bullous Pemphigoid in Infancy: Treatment with Intravenous Immunoglobulin. Pediatric Dermatology, 31: e94–e95. doi: 10.1111/pde.12360
- Issue published online: 14 JUL 2014
- Article first published online: 11 JUN 2014
Bullous pemphigoid is an autoimmune subepidermal blistering disorder that typically affects elderly adults but can also occur in childhood. We report on a 3-month-old boy who developed bullous pemphigoid 1 week after the second routine administration of a hexavalent vaccine. The disease was resistant to standard therapies (including oral and topical corticosteroids) but was relieved by intravenous immunoglobulin treatment. There was no recurrence of bullous pemphigoid after the next vaccination (3 mos after discontinuation of steroids).